Aynur Kirbas
Overview
Explore the profile of Aynur Kirbas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
307
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Bayoglu Tekin Y, Guven E, Ural U, Yazici Z, Kirbas A, Kir Sahin F
J Matern Fetal Neonatal Med
. 2015 Feb;
29(4):629-32.
PMID: 25708489
Objective: The aim of this study was to evaluate maternal neutrophil gelatinase-asssociated lipocalin (NGAL) levels and fetal renal artery (fRA) Doppler flow indices in pregnant women fasting in Ramadan in...
12.
Gumus A, Cinarka H, Karatas M, Kirbas A, Kayhan S, Sahin U
Tuberk Toraks
. 2015 Jan;
62(4):267-72.
PMID: 25581690
Introduction: Copeptin is released simultaneously along with arginine-vasopressine as a result of different stimuli from the neurohypophysis. Physiological function of copeptin is still unclear. Increased blood copeptin levels is associated...
13.
Bayoglu Tekin Y, Guven E, Kirbas A, Ustuner I, Dogan O, Balik G, et al.
J Pediatr Adolesc Gynecol
. 2015 Jan;
28(1):63-65.
PMID: 25555303
Study Objective: To determine the SCUBE1 levels in adolescents with primary dysmenorrhea. Design: A prospective cross-sectional study. Setting: A university hospital outpatient clinic, Rize, Turkey. Participants: A total of 40...
14.
Durakoglugil M, Ayaz T, Kocaman S, Kirbas A, Durakoglugil T, Erdogan T, et al.
Anatol J Cardiol
. 2014 Dec;
15(7):577-85.
PMID: 25538000
Objective: Catestatin has several cardiovascular actions, in addition to diminished sympatho-adrenal flow. Decreased plasma catestatin levels may reflect a predisposition for the development of hypertension and metabolic disorders. We planned...
15.
Bayoglu Tekin Y, Guven S, Kirbas A, Kalkan Y, Tumkaya L, Guven E
Eur J Obstet Gynecol Reprod Biol
. 2014 Dec;
184:1-6.
PMID: 25462211
Objective: Resveratrol, a phytoalexin polyphenol, has anti-angiogenic, antioxidant, anti-inflammatory properties. We aimed to compare the anti-inflammatory and anti-angiogenic effects of resveratrol and leuprolide acetate (LA) in an experimental endometriosis model....
16.
Cure E, Cure M, Tumkaya L, Kalkan Y, Aydin I, Kirbas A, et al.
Saudi J Gastroenterol
. 2014 Sep;
20(5):297-303.
PMID: 25253365
Background And Aim: Ischemia/reperfusion (I/R) injury in the liver occurs after a prolonged period of ischemia followed by restoration of hepatic blood perfusion. During the surgery of abdominal aorta, I/R...
17.
Gumus A, Ozkaya S, Ozyurt S, Cinarka H, Kirbas A, Sahin U, et al.
Multidiscip Respir Med
. 2014 Sep;
9(1):49.
PMID: 25243068
Background: The protein neutrophil gelatinase-associated lipocalin (NGAL) is a mediator synthesized and released by neutrophils. Its physiological function is as yet unclear. Levels in blood increase in several inflammatory diseases....
18.
Cure E, Kirbas A, Tumkaya L, Cure M, Sahin O, Kalkan Y, et al.
Saudi Med J
. 2014 Sep;
35(9):953-8.
PMID: 25228176
Objectives: To investigate whether infliximab (Ib), an inhibitor of tumor necrosis factor alpha (TNF-α), prevents cisplatin (Cis)-induced nephrotoxicity. Methods: The study was performed in the Department of Internal Medicine, Recep...
19.
Ayaz T, Kirbas A, Durakoglugil T, Durakoglugil M, Sahin S, Sahin O, et al.
Metab Syndr Relat Disord
. 2014 Apr;
12(5):283-9.
PMID: 24689950
Aim: This study was designed to evaluate carotid intima media thickness (CIMT) and serum osteoprotegerin (OPG) levels in nonalcoholic fatty liver disease (NAFLD) in comparison to healthy controls and to...
20.
Cure E, Cumhur Cure M, Tumkaya L, Kalkan Y, Aydin I, Kirbas A, et al.
Biomed Res Int
. 2014 Feb;
2014:907915.
PMID: 24551855
The aim of this study was to investigate the possible protective effects of adalimumab (ADA) on cell damage in rat liver tissue during ischemia/reperfusion (I/R) injury of infrarenal abdominal aorta....